Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Publications for Glen Reid Publications for Glen Reid 2016 Kao, S., Kirschner, M., Cooper, W., Tran, T., Burgers, S., Wright, C., Korse, T., van den Broek, D., Edelman, J., Vallely, M., McCaughan, B., Pavlakis, N., Clarke, S., van Zandwijk, N., Reid, G., et al (2016). A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma. British Journal of Cancer, 114(5), 524-531. <a href="http://dx.doi.org/10.1038/bjc.2015.470">[ More Information]</a> Hoda, M., Dong, Y., Rozsas, A., Klikovits, T., Laszlo, V., Ghanim, B., Stockhammer, P., Ozsvar, J., Jakopovic, M., Reid, G., van Zandwijk, N., et al (2016). Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. European Journal of Cancer, 63, 64-73. <a href="http://dx.doi.org/10.1016/j.ejca.2016.04.01 8">[More Information]</a> Reid, G., Kao, S., Pavlakis, N., Brahmbhatt, H., MacDiarmid, J., Clarke, S., Boyer, M., van Zandwijk, N. (2016). Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer. Epigenomics, 8(8), 1079-1085. <a href="http://dx.doi.org/10.2217/epi-2016-0035"> [More Information]</a> Cheng, V., Wright, C., Kirschner, M., Williams, M., Sarun, K., Sytnyk, V., Leshchynska, I., Edelman, J., Vallely, M., McCaughan, B., van Zandwijk, N., Reid, G., et al (2016). KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer, 15(1), 1-12. <a href="http://dx.doi.org/10.1186/s12943-016-052 9-z">[More Information]</a> Lin, R., Kirschner, M., Cheng, V., van Zandwijk, N., Reid, G. (2016). MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients. Genomics Data, 9, 44-49. <a href="http://dx.doi.org/10.1016/j.gdata.2016.06.0 09">[More Information]</a> van Zandwijk, N., Soeberg, M., Reid, G. (2016). Using a multidisciplinary approach to combat the burden of asbestos-related disease. Medical Journal of Australia, 204(2), 52-52.e1. <a href="http://dx.doi.org/10.5694/mja15.01209">[ More Information]</a> 2015 Kao, S., Fulham, M., Wong, K., Cooper, W., Brahmbhatt, H., MacDiarmid, J., Pattison, S., Sagong, J., Huynh, Y., Leslie, F., Pavlakis, N., Clarke, S., Boyer, M., Reid, G., van Zandwijk, N. (2015). A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma. American Journal of Respiratory and Critical Care Medicine, 191(12), 1467-1469. <a href="http://dx.doi.org/10.1164/rccm.201503-04 61LE">[More Information]</a> Klebe, S., Griggs, K., Cheng, Y., Driml, J., Henderson, D., Reid, G. (2015). Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model. Disease Markers, 2015, 1-9. <a href="http://dx.doi.org/10.1155/2015/286719">[ More Information]</a> Kirschner, M., Emily, P., Hoda, M., Rozsas, A., Griggs, K., Cheng, Y., Edelman, J., Kao, S., Hyland, R., Dong, Y., Vallely, M., van Zandwijk, N., Reid, G., et al (2015). Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis. British Journal of Cancer, 113(6), 963-969. <a href="http://dx.doi.org/10.1038/bjc.2015.286">[ More Information]</a> Birnie, K., Yip, Y., Ng, D., Kirschner, M., Reid, G., Prele, C., Musk, A., Lee, Y., Thompson, P., Mutsaers, S., et al (2015). Loss of mir-223 and JNK Signalling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma. Molecular Cancer Research, 13(7), 1106-1118. <a href="http://dx.doi.org/10.1158/1541-7786.MCR -14-0442">[More Information]</a> Lin, R., van Zandwijk, N., Reid, G. (2015). MicroRNA Therapeutics � Back in Vogue? Journal of Investigative Genomics, 2(1), 12. Glover, A., Zhao, J., Gill, A., Weiss, J., Mugridge, N., Kim, E., Feeney, A., Ip, J., Reid, G., Clarke, S., Robinson, B., Sidhu, S., et al (2015). microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma. Oncotarget, 6(34), 36675-36688. <a href="http://dx.doi.org/10.18632/oncotarget.538 3">[More Information]</a> Maher, S., Bibby, B., Moody, H., Reid, G. (2015). MicroRNAs and Cancer. In Steven G. Gray (Eds.), Epigenetic Cancer Therapy, (pp. 67-90). London: Academic Press. <a href="http://dx.doi.org/10.1016/B978-0-12-8002 06-3.00004-5">[More Information]</a> Reid, G. (2015). MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets. Journal of Thoracic Disease, 7(6), 1031-1040. <a Publications for Glen Reid href="http://dx.doi.org/10.3978/j.issn.2072-1439. 2015.04.56">[More Information]</a> Williams, M., Kirschner, M., Cheng, Y., Hanh, J., Weiss, J., Amaro-Mugridge, N., Wright, C., Linton, A., Kao, S., Edelman, J., Vallely, M., Cooper, W., van Zandwijk, N., Reid, G., et al (2015). miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget, 6(27), 23480-23495. <a href="http://dx.doi.org/10.18632/oncotarget.434 6">[More Information]</a> Kirschner, M., Cheng, Y., Armstrong, N., Lin, R., Kao, S., Linton, A., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2015). MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Molecular Oncology, 9(3), 715-726. <a href="http://dx.doi.org/10.1016/j.molonc.2014.1 1.007">[More Information]</a> 2014 Linton, A., Cheng, Y., Griggs, K., Kirschner, M., Gattani, S., Srikaran, S., Kao, S., McCaughan, B., Klebe, S., van Zandwijk, N., Reid, G. (2014). An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer, 110(2), 510-519. <a href="http://dx.doi.org/10.1038/bjc.2013.731">[ More Information]</a> Cheng, N., van Zandwijk, N., Reid, G. (2014). Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5. PloS One, 9(3), 1-10. <a href="http://dx.doi.org/10.1371/journal.pone.009 0374">[More Information]</a> 2013 Kirschner, M., van Zandwijk, N., Reid, G. (2013). Cell-free microRNAs: potential biomarkers in need of standardized reporting. Frontiers in Genetics, 4, 1-5. <a href="http://dx.doi.org/10.3389/fgene.2013.0005 6">[More Information]</a> Henderson, D., Reid, G., Kao, S., Van Zandwijk, N., Klebe, S. (2013). Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. Journal of Clinical Pathology, 66(10), 854-861. <a href="http://dx.doi.org/10.1136/jclinpath-2013-2 01609">[More Information]</a> Henderson, D., Reid, G., Kao, S., Van Zandwijk, N., Klebe, S. (2013). Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. Journal of Clinical Pathology, 66(10), 847-853. <a href="http://dx.doi.org/10.1136/jclinpath-2012-2 01303">[More Information]</a> Wright, C., Kirschner, M., Cheng, Y., O’Byrne, K., Gray, S., Schelch, K., Hoda, M., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2013). Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM). PloS One, 8(8), 1-12. <a href="http://dx.doi.org/10.1371/journal.pone.007 0940">[More Information]</a> Lim, C., Prele, C., Cheah, H., Cheng, Y., Klebe, S., Reid, G., Watkins, D., Baltic, S., Thompson, P., Mutsaers, S. (2013). Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma. PloS One, 8(6), 1-12. <a href="http://dx.doi.org/10.1371/journal.pone.006 6685">[More Information]</a> Reid, G., Pel, M., Kirschner, M., Cheng, Y., Amaro-Mugridge, N., Madrid-Weiss, J., Williams, M., Wright, C., Edelman, J., Vallely, M., van Zandwijk, N., et al (2013). Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Annals of Oncology, 24(12), 3128-3135. <a href="http://dx.doi.org/10.1093/annonc/mdt412" >[More Information]</a> Kirschner, M., Edelman, J., Kao, S., Vallely, M., van Zandwijk, N., Reid, G. (2013). The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in Genetics, 4, 1-13. <a href="http://dx.doi.org/10.3389/fgene.2013.0009 4">[More Information]</a> Cheng, Y., Kirschner, M., Cheng, N., Gattani, S., Klebe, S., Edelman, J., Vallely, M., McCaughan, B., Jin, H., van Zandwijk, N., Reid, G. (2013). ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 8(10), 1317-1328. <a href="http://dx.doi.org/10.1097/JTO.0b013e3182 a0840a">[More Information]</a> 2012 Kirschner, M., Cheng, V., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., van Zandwijk, N., Reid, G., et al (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 7(7), 1184-1191. <a href="http://dx.doi.org/10.1097/JTO.0b013e3182 572e83">[More Information]</a> Publications for Glen Reid Linton, A., van Zandwijk, N., Reid, G., Clarke, S., Cao, C., Kao, S. (2012). Inflammation in malignant mesothelioma - friend or foe? Annals of Cardiothoracic Surgery, 1(4), 516-522. <a href="http://dx.doi.org/10.3978/j.issn.2225-319X .2012.10.02">[More Information]</a> van Zandwijk, N., Reid, G., Linton, A., Kao, S. (2012). Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools? Annals of Cardiothoracic Surgery, 1(4), 481-486. <a href="http://dx.doi.org/10.3978/j.issn.2225-319X .2012.10.01">[More Information]</a> Research Notes, 4(Article 148), 1-7. <a href="http://dx.doi.org/10.1186/1756-0500-4-14 8">[More Information]</a> Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. <a href="http://dx.doi.org/10.1097/PAT.0b013e328 342016c">[More Information]</a> 2010 Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J., Reid, G., Woolley, A., Miller, L., Black, M., Braithwaite, A., et al (2012). YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth. Journal of the National Cancer Institute, 104(2), 133-46. <a href="http://dx.doi.org/10.1093/jnci/djr512">[M ore Information]</a> Lasham, A., Herbert, M., Coppieters 't Wallant, N., Patel, R., Feng, S., Eszes, M., Cao, H., Reid, G. (2010). A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe. Nucleic Acids Research, 38(3), e19 - 1-e19 - 11. <a href="http://dx.doi.org/10.1093/nar/gkp1076">[ More Information]</a> 2011 Li, Y., Revalde, J., Reid, G., Paxton, J. (2010). Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews, 42(4), 590-611. <a href="http://dx.doi.org/10.3109/0360253100375 8690">[More Information]</a> Reid, G., Kirschner, M., van Zandwijk, N. (2011). Circulating microRNAs: Association with disease and potential use as biomarkers. Critical Reviews in Oncology / Hematology, 80(2), 193-208. <a href="http://dx.doi.org/10.1016/j.critrevonc.2010 .11.004">[More Information]</a> Kirschner, M., Kao, S., Edelman, J., Armstrong, N., Vallely, M., van Zandwijk, N., Reid, G. (2011). Haemolysis during Sample Preparation Alters microRNA Content of Plasma. PloS One, 6(9), 1-9. <a href="http://dx.doi.org/10.1371/journal.pone.002 4145">[More Information]</a> Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. <a href="http://dx.doi.org/10.1097/JTO.0b013e3182 2a3740">[More Information]</a> Kao, S., Reid, G., van Zandwijk, N., Henderson, D., Klebe, S. (2011). Molecular biomarkers in malignant mesothelioma: state of the art. Pathology, 43(3), 201-212. <a href="http://dx.doi.org/10.1097/PAT.0b013e328 3445e67">[More Information]</a> Herbert, M., Coppieters 't Wallant, N., Lasham, A., Cao, H., Reid, G. (2011). The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing. BMC Li, Y., Revalde, J., Reid, G., Paxton, J. (2010). Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology. <a href="http://dx.doi.org/10.1007/s00280-010-151 5-6">[More Information]</a>